Curated News
By: NewsRamp Editorial Staff
May 21, 2025
Lionheart Health Advances as Semi-Finalist in XPRIZE Healthspan Competition
TLDR
- Lionheart Health, Inc. has advanced to the XPRIZE Healthspan Competition semi-finals, gaining recognition and $250,000, showcasing its biotechnology edge.
- Lionheart Health employs bioelectric signaling sequences to regulate protein release for muscle, cognitive, and immune restoration, aiming for a 20-year healthspan extension.
- Lionheart Health's technology may revolutionize aging by promoting regeneration and renewal, potentially enhancing longevity and overall health for individuals globally.
- Researchers at Lionheart Health have discovered a promising link between the Klotho protein and longevity, sparking exciting possibilities for future health advancements.
Impact - Why it Matters
This news highlights Lionheart Health's innovative approach to promoting healthy aging and longevity through bioelectric and stem cell-based regeneration research. The company's participation in the XPRIZE competition signifies a major milestone in the development of potential treatments that could extend healthspan and improve overall well-being for individuals worldwide.
Summary
Lionheart Health, Inc., a biotechnology company based in Orange County, California, has advanced as one of the 40 semi-finalists in the $101M XPRIZE Healthspan Competition. The company has developed a technology platform utilizing bioelectric signaling sequences to control the release of regeneration-promoting proteins, including Klotho-expressing stem cells suspended in a proprietary nutrient hydrogel. Lionheart Health aims to demonstrate a treatment that restores muscle, cognitive, and immune function by a minimum of 10 years in individuals aged 50-80 within 1 year.
Source Statement
This curated news summary relied on this press release disributed by Newsworthy.ai. Read the source press release here, Lionheart Health Advances as Semi-Finalist in XPRIZE Healthspan Competition
